Portfolio company
Amgen Europe
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and manufactures biotechnological medicines to treat patients with serious conditions such as cancer, cardiovascular disease and inflammatory disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Amgen
This biotechnology company develops and manufactures biologic medicines to treat patients with serious illnesses, including cancer, kidney disease and inflammatory disorders.
Genentech
This biotechnology company develops and manufactures medicines for patients with serious diseases including cancer, multiple sclerosis, and respiratory conditions.
ArgenX
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
Bial
This company develops and manufactures pharmaceutical medicines for patients with neurological, cardiovascular and respiratory conditions.
Amphista Therapeutics
This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.
Regeneron
This biopharmaceutical company develops medicines for serious diseases, including eye conditions, cancer and inflammatory disorders, for healthcare providers and global patients.
Actelion
This company develops and manufactures pharmaceutical drugs to treat orphan diseases such as pulmonary arterial hypertension for patients and healthcare providers globally.
Novo Nordisk
This pharmaceutical company manufactures medicines for patients living with diabetes, obesity and other serious chronic diseases.
